| Convergent antibody responses to SARS-CoV-2 in convalescent individuals DF Robbiani, C Gaebler, F Muecksch, JCC Lorenzi, Z Wang, A Cho, ... Nature, 1-8, 2020 | 2097 | 2020 |
| Evolution of antibody immunity to SARS-CoV-2 C Gaebler, Z Wang, JCC Lorenzi, F Muecksch, S Finkin, M Tokuyama, ... Nature 591 (7851), 639-644, 2021 | 1809 | 2021 |
| SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies CO Barnes, CA Jette, ME Abernathy, KMA Dam, SR Esswein, HB Gristick, ... Nature, 2020 | 1565 | 2020 |
| Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants Y Weisblum, F Schmidt, F Zhang, J DaSilva, D Poston, JCC Lorenzi, ... Elife 9, e61312, 2020 | 1530 | 2020 |
| Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo GJ Randolph, K Inaba, DF Robbiani, RM Steinman, WA Muller Immunity 11 (6), 753-761, 1999 | 1165 | 1999 |
| Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies CO Barnes, AP West Jr, KE Huey-Tubman, MAG Hoffmann, NG Sharaf, ... Cell 182 (4), 828-842. e16, 2020 | 811 | 2020 |
| The Leukotriene C 4 Transporter MRP1 Regulates CCL19 (MIP-3β, ELC)–Dependent Mobilization of Dendritic Cells to Lymph Nodes DF Robbiani, RA Finch, D Jäger, WA Muller, AC Sartorelli, GJ Randolph Cell 103 (5), 757-768, 2000 | 616 | 2000 |
| MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation Y Dorsett, KM McBride, M Jankovic, A Gazumyan, TH Thai, DF Robbiani, ... Immunity 28 (5), 630-638, 2008 | 603 | 2008 |
| Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses F Schmidt, Y Weisblum, F Muecksch, HH Hoffmann, E Michailidis, ... Journal of Experimental Medicine 217 (11), 2020 | 598 | 2020 |
| AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations DF Robbiani, A Bothmer, E Callen, B Reina-San-Martin, Y Dorsett, ... Cell 135 (6), 1028-1038, 2008 | 552 | 2008 |
| Identification of early replicating fragile sites that contribute to genome instability JH Barlow, RB Faryabi, E Callén, N Wong, A Malhowski, HT Chen, ... Cell 152 (3), 620-632, 2013 | 489 | 2013 |
| Enhanced SARS-CoV-2 neutralization by dimeric IgA Z Wang, JCC Lorenzi, F Muecksch, S Finkin, C Viant, C Gaebler, ... Science Translational Medicine, 2020 | 470 | 2020 |
| AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies M Chesi, DF Robbiani, M Sebag, WJ Chng, M Affer, R Tiedemann, ... Cancer cell 13 (2), 167-180, 2008 | 466 | 2008 |
| Rif1 Prevents Resection of DNA Breaks and Promotes Immunoglobulin Class Switching M Di Virgilio, E Callen, A Yamane, W Zhang, M Jankovic, AD Gitlin, ... Science 339 (6120), 711-715, 2013 | 460 | 2013 |
| Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes IA Klein, W Resch, M Jankovic, T Oliveira, A Yamane, H Nakahashi, ... Cell 147 (1), 95-106, 2011 | 391 | 2011 |
| Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma M Chesi, LA Brents, SA Ely, C Bais, DF Robbiani, EA Mesri, WM Kuehl, ... Blood 97 (3), 729-736, 2001 | 390 | 2001 |
| Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies AJ Greaney, TN Starr, CO Barnes, Y Weisblum, F Schmidt, M Caskey, ... Nature Communications 12 (1), 1-14, 2021 | 386 | 2021 |
| Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico DF Robbiani, L Bozzacco, JR Keeffe, R Khouri, PC Olsen, A Gazumyan, ... Cell 169 (4), 597-609. e11, 2017 | 359 | 2017 |
| 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination A Bothmer, DF Robbiani, N Feldhahn, A Gazumyan, A Nussenzweig, ... The Journal of experimental medicine 207 (4), 855, 2010 | 346 | 2010 |
| Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo A Schäfer, F Muecksch, JCC Lorenzi, SR Leist, M Cipolla, S Bournazos, ... Journal of Experimental Medicine 218 (3), 2020 | 343 | 2020 |
